Pharmacology Faculty
All of our faculty members have extensive educational backgrounds that make them exceptional sources of industry information and insights.
Feel free to contact any of the Pharmacology Program faculty listed below by clicking on the link to their email address.
Once you’ve read about the Pharmacology Program faculty members, be sure to learn more about the Pharmacology Program itself. If you have any questions or would like additional information, please contact the School of Biomedical Sciences.
| Name | Campus | Specialty | |
|---|---|---|---|
| Soumitra Basu | sbasu@kent.edu | Kent | Molecular basis of RNA structure and function, drug design. More on Basu |
| William Chilian | wchilian@neomed.edu | NEOMED | Angiogenesis, arteriogenesis, regulation of coronary blood flow, heart failure, stem cells, regenerative medicine. More on Chilian |
| Lique Coolen | jcoolen@kent.edu | Kent | Mechanisms by which spinal cord injury affects urogenital and sexual function, neurobiology of addiction and understanding neural circuits that mediate female reproductive function and dysfunction. More on Coolen |
| Mark Dalman | mdalman@kent.edu | Kent | More on Dalman |
| Altaf Darvesh | adarvesh@neomed.edu | NEOMED | Development of antioxidant and anti-inflammatory strategies for neoplastic an neurodegenerative diseases, as well as psychiatric disorders. More on Darvesh |
| Dimitrios Davalos | davalod@ccf.org | CCF | The Dimitrios Davalos lab studies the interactions between blood vessels, neurons and microglia in health and disease. More on Davalos |
| Christine Dengler-Crish | ccrish@neomed.edu | NEOMED | Early disease mechanisms in dementia; sensory system disruptions and homeostatic dysregulation in Alzheimer's disease. More on Crish |
| Feng Dong | fdong@neomed.edu | NEOMED | More on Dong |
| Jessica Ferrell | jfrancl@neomed.edu | NEOMED | More on Ferrell |
| Sheila Fleming | sfleming1@neomed.edu | NEOMED | More on Fleming |
| T. Lee Gilman | lgilman1@kent.edu | Kent | Influences of diet, stress and genetic variation on emotions, behavior, and overall brain & body health. More on Gilman. |
| Adam Goodwill | agoodwill@neomed.edu | NEOMED | Mechanisms of coronary flow control, studies of cardiac function and identification of cardioprotective pathways. More on Goodwill |
| Tariq Haqqi | thaqqi@neomed.edu | NEOMED | More on Haqqi |
| Takhar Kasumov | tkasumov@neomed.edu | NEOMED | More on Kasumov |
| Yoon-Kwang Lee | ylee3@neomed.edu | NEOMED | Structure and regulation of nuclear hormone receptors. More on Lee |
| Yong Lu | ylu@neomed.edu | NEOMED | Neurotransmitter systems, GABA, glutamate, audition. More on Lu |
| Jeffrey Mellott | jmellott@neomed.edu | NEOMED | Age-related changes to inhibitory circuitry in the auditory pathways. More on Mellott |
| Devin Mueller | dmuell10@kent.edu | Kent | Neural mechanisms of learning and memory that underlie drug use and emotional regulation. More on Mueller |
| Vahagn Ohanyan | vohanyan@neomed.edu | NEOMED | More on Ohanyan |
| Heather O'Leary | holeary@neomed.edu | NEOMED | More on O'Leary |
| Moses Oyewumi | moyewumi@neomed.edu | NEOMED | More on Oyewumi |
| Priya Raman | praman@neomed.edu | NEOMED | My lab is interested in the cellular and molecular mechanisms underlying vascular complications and Alzheimer's disease-related dementia associated with diabetes and obesity. We are studying the role of a post-translational protein modification (O-Glycosylation) and a proatherogenic matricellular protein (Thrombospondin-1) in vascular smooth muscle cell phenotypic changes and seeking to understand how targets contributed to vascular and cognitive anomalies in metabolic disorders. More on Raman |
| Erin Reed-Geaghan | ereedgeaghan@neomed.edu | NEOMED | My lab is interested in the role of the immune system in Alzheimer’s disease (AD). Specifically, we seek to understand the ways in which the brain’s resident immune cells, microglia, contribute to the neuroinflammatory processes driving neurodegeneration. We believe microglia from men and women respond differently in AD, contributing to the sex differences in disease onset and progression, and we’re working on identifying the reasons for these differences. We are also interested in how these cells communicate with the circulating peripheral immune system, and the ways in which these interactions affect disease progression. More on Reed-Geaghan |
| Prabodh Sadana | psadana@neomed.edu | NEOMED | Hormonal regulation of lipid metabolism. More on Sadana |
| Thorsten-Lars Schmidt | tschmi21@kent.edu | Kent | DNA nanotechnology-based tools and materials for single-molecule biophysics and nanomedicine. More on Schmidt |
| Xinwen Wang | xwang2@neomed.edu | NEOMED | One size does not fit all. For many patients, standard drug treatment might not work or even trigger life-threatening adverse reactions. There is an urgent clinical need to provide tailored therapy for patients. Our laboratory focuses on applying pharmaco-omics tools (i.e. pharmacogenomics, proteomics and metabolomics) to identify both genetic and non-genetic factors contributing to the interindividual variability related to disease risks and drug therapies. Our research is expected to improve the efficacy and safety of drugs by identifying biomarkers that can predict individual drug responses, revealing novel drug targets and translating these findings into clinical precision pharmacotherapy. More on Wang |
| Bradley Winters | bwinters@neomed.edu | NEOMED | Cellular neurophysiology of brainstem sound localization circuits that process timing and intensity differences between the two ears. More on Winters |
| Liya Yin | lyin@neomed.edu | NEOMED | More on Yin |
| Yanqiao Zhang | yzhang@neomed.edu | NEOMED | Regulation of lipid and glucose metabolism under normal and disease conditions. More on Zhang |
| Yaorong Zheng | yzheng7@kent.edu | Kent | More on Zheng |